Exploring the ElectroRetinoGraphy as a biomarker for predicting and monitoring therapeutic response to antidepressants in major depressive disorder: study protocol for the MESANTIDEP trial

Exploring the ElectroRetinoGraphy as a biomarker for predicting and monitoring therapeutic response to antidepressants in major depressive disorder: study protocol for the MESANTIDEP trial

BackgroundMajor depressive disorder (MDD) is a frequent and highly debilitating condition for which current antidepressant treatments show limited effectiveness. In addition, their implementation requires one or more trial-and-error processes, which involves months of untreated illness. Achieving fa...

Full description

Saved in:
Bibliographic Details
Main Authors: Marie de Deus, Charlotte Petit, Marie Moulard, Eve Cosker, Naoual Mellouki Bendimred, Éliane Albuisson, Julia Maruani, Pierre-Alexis Geoffroy, Thomas Schwitzer
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Psychiatry
Subjects:
antidepressant
ElectroRetinoGraphy
major depressive disorder
precision psychiatry
retinal function
SSRI
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2025.1501166/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fpsyt.2025.1501166/full

Similar Items